IR-Med (IRME) Return on Capital Employed (2021 - 2025)

IR-Med's Return on Capital Employed history runs 5 years deep, the most recent figure standing at 234.43% for Q2 2025.

• In Q2 2025, Return on Capital Employed changed N/A year-over-year to 234.43%; the TTM figure through Jun 2025 stood at 234.43% (changed N/A YoY), while the FY2024 annual figure was 2426.25%, down 213279.0% from the prior year.
• Return on Capital Employed came in at 234.43% for Q2 2025 at IR-Med, down from 357.63% in the prior quarter.
• In the past five years, Return on Capital Employed ranged from a high of 1268.63% in Q4 2024 to a low of 537.9% in Q4 2023.
• A 5-year average of 18.85% and a median of 156.31% in 2022 frame the typical range for Return on Capital Employed.
• Across the five-year window, Return on Capital Employed slumped 38159 bps in 2023 and surged 180652 bps in 2024, its largest moves.
• IR-Med's Return on Capital Employed stood at 125.63% in 2021, then retreated by 24 bps to 156.31% in 2022, then tumbled by 244 bps to 537.9% in 2023, then soared by 336 bps to 1268.63% in 2024, then tumbled by 82 bps to 234.43% in 2025.
• According to Business Quant data, Return on Capital Employed over the past three periods registered 234.43%, 357.63%, and 1268.63% for Q2 2025, Q1 2025, and Q4 2024 respectively.

Peer Comparison